Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: Wolters Kluwer 2025-01-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000003307
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841550808145985536
collection DOAJ
format Article
id doaj-art-e8e9f7c27df448cc8c0a83706613446c
institution Kabale University
issn 0366-6999
2542-5641
language English
publishDate 2025-01-01
publisher Wolters Kluwer
record_format Article
series Chinese Medical Journal
spelling doaj-art-e8e9f7c27df448cc8c0a83706613446c2025-01-10T01:10:37ZengWolters KluwerChinese Medical Journal0366-69992542-56412025-01-011381676710.1097/CM9.0000000000003307202501050-00020Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathwayhttp://journals.lww.com/10.1097/CM9.0000000000003307
spellingShingle Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
Chinese Medical Journal
title Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
title_full Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
title_fullStr Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
title_full_unstemmed Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
title_short Corrigendum: UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
title_sort corrigendum ube2c affects breast cancer proliferation through the akt mtor signaling pathway
url http://journals.lww.com/10.1097/CM9.0000000000003307